EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Flow cytometry protocol for cell death analysis in glioblastoma organoids: A technical note

Anna-Laura Potthoff iD, Meng-Chun Hsieh, Ahmad Melhem, Susanna S Ng, Barbara E F Pregler, Annika Vieregge, Markus Raspe, Lea L Friker, Thomas Zeyen, Julian P Layer iD, Andreas Dolf, Marieta I Toma und 7 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0327660 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Anna-Laura Potthoff und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Glioblastoma, Organoids, Flow Cytometry, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mildred Scheel School of Oncology Cologne-Bonn, Ministry of Culture and Science of the State of North Rhine-Westphalia, Medizinische Fakultät, Rheinische Friedrich-Wilhelms-Universität Bonn.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor organoid models have emerged as a promising tool in cancer research. By preserving intra- and intertumoral heterogeneity and structural integrity they provide a physiologically relevant platform for drug-response studies. However, valid methodological approaches for cell death analyses applying flow cytometry, particularly in complex, large organoids, are lacking. Using glioblastoma organoids (GBOs), we developed a flow cytometry protocol to quantify cell death as an important readout in cancer research. Human GBOs were generated out of tumor material from six patients. Temozolomide (TMZ) and lomustine (CCNU) were used as cytotoxic agents commonly employed in glioblastoma therapy. After treatment for 144 and 288 hours, single cell suspensions from densely-packed GBOs were generated through a combined approach of enzymatic and mechanical dissociation. Cells were permeabilized with Triton X and subsequently stained with propidium iodide (PI). PI staining labels fragmented nuclear DNA, yielding a hypodiploid sub-G1 peak in flow cytometry that markes cell death. After treatment for 288 hours with physiologically-relevant concentrations of TMZ and CCNU cell death rates reached up to 63% in our GBO model. Across three GBO populations, the impact of CCNU at the given concentration was more pronounced compared to that observed with TMZ and the cell death rates of treatment for 288 hours surpassed that of the 144-hour treatment. Both biological and technical replicates showed low variability. Hoechst 33258 staining on the same samples confirmed trends in cell death rates obtained from PI-based analysis. We further validated the treatment-induced effect using a plate-based lactate dehydrogenase release assay and measurements of GBO diameter. Our single-stain flow-cytometry protocol scales to large, dense organoids and provides a practical balance of performance, hands-on time, cost, specificity, and throughput. This protocol could support development and evaluation of subtype-specific therapeutic strategies in translational cancer research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaOrganoidsFlow CytometryBrain NeoplasmsHumansTemozolomideCell DeathLomustineDacarbazine

Substanzen

TemozolomideLomustineDacarbazine

Autor:innen und Institutionen

  • Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.
  • Brain Tumor Translational Research Group, University Hospital Bonn, Bonn, Germany.
  • Institute of Neuropathology, University Hospital Bonn, Bonn, Germany.
  • Institute of Experimental Oncology, University Hospital Bonn, Bonn, Germany.
  • Department of Neurooncology, Center for Neurology, University Hospital Bonn, Bonn, Germany.
  • Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany.

ORCID-Profile: Anna-Laura Potthoff, Julian P Layer

Förderung

  • Mildred Scheel School of Oncology Cologne-Bonn
  • Ministry of Culture and Science of the State of North Rhine-Westphalia
  • Medizinische Fakultät, Rheinische Friedrich-Wilhelms-Universität Bonn

Zitieren

APA

Potthoff, A. L., Hsieh, M. C., Melhem, A., Ng, S. S., Pregler, B. E. F., Vieregge, A., Raspe, M., Friker, L. L., Zeyen, T., Layer, J. P., Dolf, A., Toma, M. I., Waha, A., Pietsch, T., Westhoff, M. A., Vatter, H., Hölzel, M., Herrlinger, U., & Schneider, M. (2025). Flow cytometry protocol for cell death analysis in glioblastoma organoids: A technical note. PLOS One. https://doi.org/10.1371/journal.pone.0327660

Vancouver

Potthoff AL, Hsieh MC, Melhem A, Ng SS, Pregler BEF, Vieregge A, et al. Flow cytometry protocol for cell death analysis in glioblastoma organoids: A technical note. PLOS One. 2025. doi:10.1371/journal.pone.0327660

BibTeX
@article{Potthoff2025,
  author = {Potthoff, Anna-Laura and Hsieh, Meng-Chun and Melhem, Ahmad and Ng, Susanna S and Pregler, Barbara E F and Vieregge, Annika and Raspe, Markus and Friker, Lea L and Zeyen, Thomas and Layer, Julian P and Dolf, Andreas and Toma, Marieta I and Waha, Andreas and Pietsch, Torsten and Westhoff, Mike-Andrew and Vatter, Hartmut and Hölzel, Michael and Herrlinger, Ulrich and Schneider, Matthias},
  title = {Flow cytometry protocol for cell death analysis in glioblastoma organoids: A technical note},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0327660}
}
Kostenlos starten →